#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4821184	B	Antagonist activity at human alpha7 nAChR expressed in Xenopus laevis oocytes assessed as inhibition of Ach-induced response incubated for 5 mins by two electrode voltage-clamp assay	Homo sapiens	2		cell-based format	Scientific Literature
2.	ALA4821188	B	Antagonist activity at human alpha9/alpha10 nAChR expressed in Xenopus laevis oocytes assessed as inhibition of Ach-induced response at 30 uM incubated for 5 mins by two electrode voltage-clamp assay	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA4821189	B	Antagonist activity at human alpha3beta2 nAChR expressed in Xenopus laevis oocytes assessed as inhibition of Ach-induced response at 30 uM incubated for 5 mins by two electrode voltage-clamp assay relative to control	Homo sapiens	2		cell-based format	Scientific Literature
4.	ALA4821190	B	Agonist activity at human GABAB expressed in HEK293T cells co-transfected with human CaV2.2-alpha1B channel assessed as inhibition of CaV2.2-mediated Ba2+ peak-current amplitude at 100 nM at -80 to 10 mV holding potential after 72 hrs by whole cell patch clamp assay relative to control	Homo sapiens	3		cell-based format	Scientific Literature
5.	ALA4821191	B	Agonist activity at human GABAB expressed in HEK293T cells co-transfected with human CaV2.2-alpha2delta1 channel assessed as inhibition of CaV2.2-mediated Ba2+ peak-current amplitude at 100 nM at -80 to 10 mV holding potential after 72 hrs by whole cell patch clamp assay relative to control	Homo sapiens	3		cell-based format	Scientific Literature
6.	ALA4821192	B	Agonist activity at human GABAB expressed in HEK293T cells co-transfected with human CaV2.2-beta3 channel assessed as inhibition of CaV2.2-mediated Ba2+ peak-current amplitude at 100 nM at -80 to 10 mV holding potential after 72 hrs by whole cell patch clamp assay relative to control	Homo sapiens	3		cell-based format	Scientific Literature
7.	ALA4821193	B	Agonist activity at human GABAB expressed in HEK293T cells co-transfected with human CaV2.2 channel assessed as inhibition of CaV2.2-mediated Ba2+ peak-current amplitude at -80 to 10 mV holding potential after 72 hrs by whole cell patch clamp assay	Homo sapiens	2		cell-based format	Scientific Literature
8.	ALA4821195	F	Antiallodynic activity in Sprague-Dawley rat model of neuropathic mechanical allodynia assessed as increase in paw withdrawal threshold administered intramuscularly measured at 1 to 24 hrs post last dose by von Frey test	Rattus norvegicus	1		organism-based format	Scientific Literature
9.	ALA4821196	F	Antiallodynic activity in Sprague-Dawley rat model of neuropathic mechanical allodynia assessed as increase in paw withdrawal threshold at 0.1 mg/kg, IM measured at 1 hr post last dose by von Frey test	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA4821197	F	Antiallodynic activity in Sprague-Dawley rat model of neuropathic mechanical allodynia assessed as increase in paw withdrawal threshold at 0.1 mg/kg, IM measured at 2 hr post last dose by von Frey test	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA4821198	F	Antiallodynic activity in Sprague-Dawley rat model of neuropathic mechanical allodynia assessed as increase in paw withdrawal threshold at 0.1 mg/kg, IM measured at 4 hr post last dose by von Frey test	Rattus norvegicus	1		organism-based format	Scientific Literature
12.	ALA4821199	F	Antiallodynic activity in Sprague-Dawley rat model of neuropathic mechanical allodynia assessed as increase in paw withdrawal threshold at 0.1 mg/kg, IM measured at 6 hr post last dose by von Frey test	Rattus norvegicus	1		organism-based format	Scientific Literature
13.	ALA4821200	F	Antiallodynic activity in Sprague-Dawley rat model of neuropathic mechanical allodynia assessed as increase in paw withdrawal threshold at 0.1 mg/kg, IM measured at 24 hrs post last dose by von Frey test	Rattus norvegicus	1		organism-based format	Scientific Literature